A Randomized Phase 2 Study of Erlotinib Alone and in Combination with Bortezomib in Previously Treated Advanced Non-small Cell Lung Cancer - Concepedia

Concepedia

Publication | Open Access

A Randomized Phase 2 Study of Erlotinib Alone and in Combination with Bortezomib in Previously Treated Advanced Non-small Cell Lung Cancer

DOI Full Paper Access

64

Citations

44

References

2009

Year

Thomas J. Lynch, David Fenton, Vera Hirsh, David Bodkin, Edward L. Middleman, Alberto Chiappori, Balázs Halmos, Reyna Favis, Hua Liu, William L. Trepicchio,

Journal of Thoracic Oncology

Randomized Phase 2MedicinePharmacologyPathologyAnti-cancer AgentCancer TreatmentOncologyRadiation OncologyLung CancerMolecular OncologyErlotinib Alone

References

	Year	Citations

Page 1

Page 1